Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

Patent Intelligence

Lead the generic drug market With this one effective strategy

Closely monitoring the patent expirations of well-known branded drugs, such as Abilify for schizophrenia and  Abaraxane for cancer treatment, is essential. This practice of monitoring patents can give generic drug

The Skill Of Asking The Right Questions For Effective Patent Infringement Analysis

Developing the ability to ask pertinent and thought-provoking questions is an essential skill for intellectual property (IP) researchers to stay on top of their work in the fast-moving field. The

Maximize SEP Licensing Damages Using WFA’s Product Finder

The recent WLAN standard mentions the word “optional” more than 1700 times, leading to ambiguity in patent scope. Eventually, potential licensees may use the ambiguity around optional features to challenge

Uncover Crucial Business Insights With ASEAN patentscope

Patent data, especially patent claims, can help with various tasks, such as assessing the market, analyzing competitors, identifying innovative trends, evaluating risks, and devising market-entry strategies. Such patent information is

Invalidating a MedTech Patent Using 102 prior art in textile industry

During invalidation searches, I often stumble upon 102 prior art from my surroundings. It might fascinate you how I discover them even when I’m not looking for them consciously. However,

Invalidating an Inventor's Patent With Research Grant Proposal

This is the story of a project that challenged me to invalidate a patent by one of the pioneers in the field of next-gen gene sequencing with over two decades

Purchasing a Patent Portfolio? Consider these 15 critical factors

If patents are your bread and butter, you know as much as I do that a thorough patent portfolio analysis is critical before deciding to buy them. However, the situation

Loteprednol Etabonate Tap into the Generic Drug’s Transformational Potential

In 2020, the FDA approved loteprednol etabonate ophthalmic suspension 0.25% (Eysuvis, Kala Pharmaceuticals Inc.) for treating dry eye disease. As one of the most common ocular surface disorders, dry eye

Patent Litigation Funding 8 Mistakes you can’t afford to make

This year, Colibri Heart Valve, a medical device start-up, went into a legal battle against the industry giant Medtronic CoreValve. This case not only earned its place among the top

3 stage framework: analyzing IP for mergers and acquisitions

Mergers and acquisitions have been a core business strategy for companies across almost all industries. A key reason for M&A deals today is the need to harness cutting-edge technologies through

Buying a patent portfolio? Do not skip this analysis!

You are considering investing millions of dollars in purchasing a patent portfolio. While this decision offers an attractive opportunity to open doors to novel technological horizons and potentially gain substantial

GreyB’s Secret Search Strategy Found Prior Art For Auto-Playing Media

The ecosystem of a patent and its technology are critical factors in conducting a prior art search and even selecting the appropriate researcher for your case. Moreover, in one of

Why is drug exclusivity knowledge crucial for generic drug launches?

Monitoring the drug exclusivity expiration timelines is just as important as patent expiration date when identifying opportunities and timing generic launches. Having access to detailed exclusivity data can reveal openings

Top 20 Patent Buyers Of Cancer Curing Technologies

During the second quarter of 2023, there was a 7% increase in patent applications for immuno-oncology compared to the previous quarter, indicating a dynamic transformation in the oncology landscape. Interestingly,

Be the First to get ANDA Approval for a Generic Drug

With companies filing for ANDAs, the global prescribed generics sales are expected to reach nearly 100 billion U.S. dollars by 2026. One example of this is Rexulti – a prescription medicine

Inside IP CommScope

In the fast-evolving landscape of telecommunications, where innovation dictates leadership, companies with robust intellectual property portfolios stand apart. CommScope, a global leader in connectivity solutions, exemplifies this strategic advantage. Its